// App-Quantinova.ai

Su2062 : PREDICTION OF TREATMENT RESPONSE IN Crohn's DISEASE PATIENTS USING CONTRAST ENHANCED ULTRASOUND: A PILOT STUDY

Researchers

Presenter

  • Mostafa Atri

Principal Investigators

  • Eran Zittan

  • Amir Nazarian

  • A. Hillary Steinhart

  • Mark S. Silverberg

Medical Centers

  • Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.

  • Joint Department of Medical Imaging, University Health Network and Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada

  • Division of Gastroenterology, Emek Medical Center, Afula, Israel

  • Division of Rheumatology, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada

Locations

  • Canada

  • Israel

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • N/A

Biomarkers

  • Aryl hydrocarbon receptor nuclear translocator-like protein 1

  • C reactive protein

Drug/Treatment

  • Perflutren

Outcome

  • Unknown

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved